Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKD 1.16

(0.0%)

Operating Income Summary of Dawnrays Pharmaceutical (Holdings) Limited

  • Dawnrays Pharmaceutical (Holdings) Limited's latest annual operating income in 2023 was 431.38 Million CNY , down -32.69% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited's latest quarterly operating income in 2023 FY was 275.98 Million CNY , down -32.69% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported an annual operating income of 410.02 Million CNY in 2022, up 7.69% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported an annual operating income of 380.76 Million CNY in 2021, up 18.8% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly operating income of 191.12 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly operating income of 84.86 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Historical Annual Operating Income of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Year Operating Income Operating Income Growth
2023 431.38 Million CNY -32.69%
2022 410.02 Million CNY 7.69%
2021 380.76 Million CNY 18.8%
2020 320.49 Million CNY 10.38%
2019 290.35 Million CNY -15.85%
2018 345.05 Million CNY 0.89%
2017 342.02 Million CNY 10.68%
2016 309.03 Million CNY -11.0%
2015 347.23 Million CNY 42.91%
2014 242.96 Million CNY 38.55%
2013 175.36 Million CNY 18.91%
2012 147.48 Million CNY -18.67%
2011 181.34 Million CNY -13.41%
2010 209.42 Million CNY 37.91%
2009 151.85 Million CNY 30.85%
2008 116.05 Million CNY 8.25%
2007 107.21 Million CNY 59.19%
2006 67.35 Million CNY -35.36%
2005 104.19 Million CNY 23.37%
2004 84.45 Million CNY -24.93%
2003 112.5 Million CNY 11.84%
2002 100.59 Million CNY 0.0%

Peer Operating Income Comparison of Dawnrays Pharmaceutical (Holdings) Limited

Name Operating Income Operating Income Difference
Pak Fah Yeow International Limited 143.01 Million HKD -201.641%
Grand Pharmaceutical Group Limited 2.66 Billion HKD 83.803%
Extrawell Pharmaceutical Holdings Limited -8.16 Million HKD 5385.261%
Wai Yuen Tong Medicine Holdings Limited 40.88 Million HKD -955.242%
Qianhai Health Holdings Limited -52.18 Million HKD 926.673%
Lee's Pharmaceutical Holdings Limited 36.04 Million HKD -1096.89%
Essex Bio-Technology Limited 310.32 Million HKD -39.008%
Tongfang Kontafarma Holdings Limited - HKD -Infinity%
PuraPharm Corporation Limited -66.04 Million HKD 753.155%
SSY Group Limited 1.63 Billion HKD 73.679%
JBM (Healthcare) Limited 174.2 Million HKD -147.63%
Jacobson Pharma Corporation Limited 333.12 Million HKD -29.495%
China Resources Pharmaceutical Group Limited 12.14 Billion HKD 96.449%